Multidrug-Resistant Transporter Mdr1p-Mediated Uptake of a Novel Antifungal Compound
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multidrug-Resistant Transporter Mdr1p-Mediated Uptake of a Novel Antifungal Compound
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 57, Issue 12, Pages 5931-5939
Publisher
American Society for Microbiology
Online
2013-09-17
DOI
10.1128/aac.01504-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- Azole Susceptibility and Transcriptome Profiling in Candida albicans Mitochondrial Electron Transport Chain Complex I Mutants
- (2012) Nuo Sun et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2)
- (2012) Kee W. Tan et al. FOOD CHEMISTRY
- Caloric restriction restores the chronological life span of the goa1 null mutant of Candida albicans in spite of high cell levels of ROS
- (2012) Hui Chen et al. FUNGAL GENETICS AND BIOLOGY
- Global Gene Deletion Analysis Exploring Yeast Filamentous Growth
- (2012) O. Ryan et al. SCIENCE
- Hidden Killers: Human Fungal Infections
- (2012) G. D. Brown et al. Science Translational Medicine
- Regulation of Efflux Pump Expression and Drug Resistance by the Transcription Factors Mrr1, Upc2, and Cap1 in Candida albicans
- (2011) Sabrina Schubert et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Monoamine Oxidase A Inhibitor Clorgyline Is a Broad-Spectrum Inhibitor of Fungal ABC and MFS Transporter Efflux Pump Activities Which Reverses the Azole Resistance of Candida albicans and Candida glabrata Clinical Isolates
- (2011) Ann R. Holmes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mitochondria and Fungal Pathogenesis: Drug Tolerance, Virulence, and Potential for Antifungal Therapy
- (2011) Miguel Shingu-Vazquez et al. EUKARYOTIC CELL
- Enzymatic Dysfunction of Mitochondrial Complex I of the Candida albicansgoa1Mutant Is Associated with Increased Reactive Oxidants and Cell Death
- (2011) Dongmei Li et al. EUKARYOTIC CELL
- Histatin 5 Uptake byCandida albicansUtilizes Polyamine Transporters Dur3 and Dur31 Proteins
- (2011) Rohitashw Kumar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Emerging opportunistic yeast infections
- (2011) Marisa H Miceli et al. LANCET INFECTIOUS DISEASES
- Methods for usingGalleria mellonellaas a model host to study fungal pathogenesis
- (2011) Beth Burgwyn Fuchs et al. Virulence
- Genetic Dissection of Azole Resistance Mechanisms in Candida albicans and Their Validation in a Mouse Model of Disseminated Infection
- (2010) D. M. MacCallum et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature
- (2010) Florent Morio et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- An insight into the antifungal pipeline: selected new molecules and beyond
- (2010) Luis Ostrosky-Zeichner et al. NATURE REVIEWS DRUG DISCOVERY
- Azole Drugs Are Imported By Facilitated Diffusion in Candida albicans and Other Pathogenic Fungi
- (2010) Bryce E. Mansfield et al. PLoS Pathogens
- Relative Contributions of the Candida albicans ABC Transporters Cdr1p and Cdr2p to Clinical Azole Resistance
- (2009) S. Tsao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux-Mediated Antifungal Drug Resistance
- (2009) R. D. Cannon et al. CLINICAL MICROBIOLOGY REVIEWS
- Goa1p ofCandida albicansLocalizes to the Mitochondria during Stress and Is Required for Mitochondrial Function and Virulence
- (2009) Adrienne Bambach et al. EUKARYOTIC CELL
- Nosocomial candidemia at a general hospital: prognostic factors and impact of early empiric treatment on outcome (2002–2005)
- (2009) Joaquín Gómez et al. MEDICINA CLINICA
- Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease
- (2009) Leah E. Cowen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Micafungin activity against Candida albicans with diverse azole resistance phenotypes
- (2008) T. S. Richards et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mutations in the multi-drug resistance regulatorMRR1, followed by loss of heterozygosity, are the main cause ofMDR1overexpression in fluconazole-resistantCandida albicansstrains
- (2008) Nico Dunkel et al. MOLECULAR MICROBIOLOGY
- The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype
- (2008) Leah E. Cowen NATURE REVIEWS MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now